Abstract:Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by blood clots and pregnancy complications due to antiphospholipid antibodies. Catastrophic APS (CAPS), a severe variant, leads to multiorgan failure and is often fatal. Pathogenesis involves antiphospholipid antibodies, particularly anti-beta-2-glycoprotein I (aβ2GPI), which trigger endothelial cell (EC) activation, cytokine release, and a prothrombotic state. Infections, surgeries, and other triggers can precipitate CAPS, leading to widespread microthromboses and systemic inflammatory responses. CAPS predominantly affects younger patients and those with systemic lupus erythematosus (SLE), with a high mortality rate, though recent treatment advances have improved survival. Diagnosing CAPS involves identifying clinical manifestations, including rapid organ involvement and small vessel occlusions, confirmed by histopathology and high antiphospholipid antibody levels. The CAPS registry data indicate that commonly affected organs include kidneys, lungs, central nervous system, and the heart, with a high prevalence of lupus anticoagulant and anticardiolipin antibodies (aCL). Current management strategies focus on therapeutic anticoagulation, immunosuppressive therapies like corticosteroids, and adjunct treatments such as plasmapheresis and intravenous immunoglobulin (IVIG). Early use of glucocorticoids and combination therapy has significantly improved outcomes. In life-threatening cases, especially with microangiopathy, experts recommend performing plasma exchange (PE). Patients with associated autoimmune conditions or refractory cases may receive cyclophosphamide (CY) and rituximab while considering PE for treatment. Maintenance of anticoagulation with an appropriate international normalized ratio (INR) is crucial to prevent recurrence. This article reviews the pathogenesis and epidemiology of CAPS. It also examines the current management strategies, and discusses the challenges and controversies associated with these strategies. It hereafter offers recommendations for future management and outlines directions for further research.

Catastrophic antiphospholipid syndrome with Epstein-Barr virus-associated hemophagocytosis: A clinicopathological conference

Catastrophic antiphospholipid syndrome: a case report and literature review

A Case of Catastrophic Antiphospholipid Syndrome with Acute Multiorgan Thrombosis and Concerns for Re-Emergence

Systemic Embolism Following Mechanical Thrombectomy for Acute Ischemic Stroke: A Case of Suspected Catastrophic Antiphospholipid Syndrome

Catastrophic antiphospholipid syndrome: Lessons from the "CAPS Registry"

Epstein-Barr virus infection associated polymyositis and coronary artery dilation

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

Extensive Thrombosis in Catastrophic Antiphospholipid Syndrome in a Newly Diagnosed Systemic Lupus Erythematosus: A Case Report

Catastrophic Antiphospholipid Syndrome: A Life-Threatening Condition

Catastrophic Antiphospholid Syndrome - An Unusual Case Report

Catastrophic antiphospholipid syndrome accompanied by complement regulatory gene mutation

Catastrophic Antiphospholipid Syndrome: A Review of Current Evidence and Future Management Practices

Catastrophic antiphospholipid syndrome and pregnancy. Clinical report

Multidisciplinary Treatment of Chronic Active Epstein-Barr Virus Infection with Multiple Complications: a Case Report

Primary catastrophic antiphospholipid syndrome in children with midbrain infarction: a case report

Dramatic devastative complications in a patient with catastrophic antiphospholipid syndrome: A Case report and literature review

Catastrophic Antiphospholipid Syndrome in a Lupus Patient With Severe Recurrent Life-Threatening Clinical Manifestations

What we know and what we don’t know about catastrophic antiphospholipid syndrome

Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): lessons from the "CAPS Registry"

Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed

Antiphospholipid Syndrome: a Survey of Clinical Characters in Ten Cases